Does the nadir CA125 concentration predict a long-term outcome after chemotherapy for carcinoma of the ovary?
| Autor: | S. M. Crawford, J. Peace |
|---|---|
| Rok vydání: | 2005 |
| Předmět: |
medicine.medical_specialty
Databases Factual endocrine system diseases medicine.medical_treatment Ovary Gastroenterology Group B Predictive Value of Tests Reference Values Internal medicine Biomarkers Tumor medicine Carcinoma Humans Survival analysis Retrospective Studies Ovarian Neoplasms Chemotherapy business.industry Hematology Prognosis medicine.disease Survival Analysis Chemotherapy regimen Surgery Treatment Outcome medicine.anatomical_structure Oncology CA-125 Antigen Predictive value of tests Disease Progression Female business Nadir (topography) |
| Zdroj: | Annals of Oncology. 16:47-50 |
| ISSN: | 0923-7534 |
| DOI: | 10.1093/annonc/mdi012 |
| Popis: | The tumour marker CA125 is an important indicator of the clinical progress of women with carcinoma of the ovary. We have investigated the interval from the nadir CA125 value to progression defined by rising CA125 (time to biochemical progression, TBP), and overall survival of patients treated with chemotherapy for this disease in relation to the nadir CA125 value in patients in whom this was |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|